ASH 2021 - Physician's Weekly


ASH 2021

Delayed Start of Therapy Feasible in Some Patients With MCL

Currently, the effect of the diagnosis-to-treatment interval (DTI) on survival in patients with mantle cell lymphoma (MCL) has not been extensively examined. Researchers aimed to determine the feasibility of active surveillance...

Addition of Ibrutinib to Chemoimmunotherapy in CLL

The combination of fludarabine, cyclophosphamide, and rituximab (FCR) is the only regimen other than allotransplantation shown in studies to result in a significant chance of functional cure in very long-term follow-up for...

Reduced risk of Alzheimer’s disease in CHIP carriers

Clonal hematopoiesis of indeterminate potential (CHIP) was related to decreased risk of Alzheimer’s disease (AD) and AD neuropathological changes. Mutated hematopoietic stem cells were detected in the brains of CHIP carriers....



For latest news and updates
Email-id is invalid